Obesity Featured Articles

  1. Regeneron Trials Balance Quest For "Scientific Truth" With Patient Impact 6/3/2025

    Regeneron’s Andres Sirulnik, MD, Ph.D., discusses the importance of seeking "scientific truth" and an unwavering commitment to patient centricity in the context of the company’s hematology research.

  2. Radiopharmaceuticals: Navigating FDA Guidance And CMC Considerations 6/2/2025

    The unique nature of radiopharmaceuticals necessitates specialized regulatory considerations, particularly for chemistry, manufacturing, and controls (CMC).

  3. Key Criteria For Choosing The Right Phase 1 CRO 6/2/2025

    What steps can you take to select the best CRO partner for your Phase 1 clinical trial?

  4. Why Perfect Clinical Trial Data Is A Dangerous Myth 6/2/2025

    Former FDA inspector Kara Harrison reveals clinical trials fail due to overcomplex designs, checklist-driven monitoring that misses critical issues, and lack of focus on what actually matters for patient safety and data integrity.

  5. The Future Of Clinical Trials Is Neurodiverse 6/2/2025

    If we want efficient and equitable trials, says Brianna Polite, we must include clinical research professionals across the spectrum of human cognition, particularly neurodivergent thinkers.

  6. The Streetlight Effect 5/30/2025

    Examine the shortcomings of existing clinical trial finders, particularly regarding the accessibility of eligibility criteria for patients seeking treatment options.

  7. What Treatment Options Do You Have For Me? 5/30/2025

    Examine the complexities surrounding patient access to treatment options, particularly in the context of clinical trials.

  8. Shape How Patients Find Clinical Trial Treatment Options 5/30/2025

    Inspired by insights shared at the recent Patients as Partners conference, Carebox is working to empower patients and caregivers navigating the often complex landscape of clinical trials.

  9. Why Biotech CRO Partnerships Are Essential For Clinical Trial Success 5/29/2025

    For early-stage biotech companies, the road from discovery to market is fraught with challenges, and in this environment, strategic partnerships with Contract Research Organizations (CROs) have become a cornerstone of clinical success.

  10. eSource vs. EDC: Reimagining Your Clinical Trials 5/29/2025

    Explore how an eSource approach to clinical trial data can reduce site burden, eliminate double data entry, minimize queries, and enhance remote monitoring.